Can B Corp (NASC) stock
NASCOTCWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends December 31
Financials through Q3 FY2024, quarter ended Sep 30, 2024Last filing: 10-Q on Nov 19, 2024
$0.01−0.00 (-1.32%)
Close on Oct 19, 2026Market cap $981.54KP/E –Yield –
Can B price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Can B's price to sales ratio was 1.0× on Oct 19, 2026, against 1.2× a year earlier. Over the last 5 years it ranged from 0.0× to 4.6×, with a median of 1.0×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 1.0× | −0.1 |
| 2025 | Dec 31, 2025 | 1.1× | −1.3 |
| 2024 | Dec 31, 2024 | 2.4× | +2.2 |
| 2023 | Dec 29, 2023 | 0.3× | −0.3 |
| 2022 | Dec 30, 2022 | 0.6× | −3.8 |
| 2021 | Dec 31, 2021 | 4.4× | +3.0 |
| 2020 | Dec 31, 2020 | 1.4× | −2.9 |
| 2019 | Dec 31, 2019 | 4.3× | −59.4 |
| 2018 | Dec 31, 2018 | 63.7× | −1.6 |
| 2017 | Dec 29, 2017 | 65.3× | +21.1 |
| 2016 | Dec 30, 2016 | 44.2× | – |
See a number that looks wrong?